July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
CEP290 mutation spectrum in Germany and delineation of the associated phenotype
Author Affiliations & Notes
  • Ditta Zobor
    Institute for Ophthalmic Research, University of Tübingen, Germany, Tübingen, Germany
  • Britta Feldhaus
    Institute for Ophthalmic Research, University of Tübingen, Germany, Tübingen, Germany
  • Nicole Weisschuh
    Molecular Genetics Laboratory,Institute for Ophthalmic Research, University of Tübingen, Germany, Tübingen, Germany
  • Fadi Nasser
    Institute for Ophthalmic Research, University of Tübingen, Germany, Tübingen, Germany
  • Eberhart Zrenner
    Institute for Ophthalmic Research, University of Tübingen, Germany, Tübingen, Germany
    Werner Reichardt Center for Integrative Neuroscience, University of Tübingen, Germany, Tübingen, Germany
  • Susanne Kohl
    Molecular Genetics Laboratory,Institute for Ophthalmic Research, University of Tübingen, Germany, Tübingen, Germany
  • Footnotes
    Commercial Relationships   Ditta Zobor, None; Britta Feldhaus, None; Nicole Weisschuh, None; Fadi Nasser, None; Eberhart Zrenner, None; Susanne Kohl, None
  • Footnotes
    Support  Supported by a ProRetina Germany grant (Pro-Re/Project/Zobor.1-2016) to BF, SK and DZ and by DFG grant (EXC 307, CIN) to EZ.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 23. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ditta Zobor, Britta Feldhaus, Nicole Weisschuh, Fadi Nasser, Eberhart Zrenner, Susanne Kohl; CEP290 mutation spectrum in Germany and delineation of the associated phenotype. Invest. Ophthalmol. Vis. Sci. 2018;59(9):23.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Gene therapy for Leber congenital amaurosis (LCA) is becoming available. Therefore, genetic testing and clinical characterization of patients are crucial. We report the spectrum of CEP290 mutations in the largest German cohort and delineate the associated phenotype.

Methods : Twenty-four patients from 22 families with genetically confirmed mutations in CEP290 were included. Genomic DNA was analyzed by Sanger sequencing or by high-throughput sequencing for all RP-related genes and segregation analysis in a research or diagnostic-genetic set-up. All patients underwent ophthalmological examination including psychophysical tests and electrophysiology, where possible. Additionally, fundus autofluorescence (FAF) and spectral domain optical coherence tomography (SD-OCT) were performed.

Results : In 24 patients (12 m, 12 f; mean age 31±18.7 years, range 4-72 years), 15 different CEP290 genotypes and 19 mutations were revealed. The most frequent mutation was c.2991+1655A>G, found in 80% (19/24) of patients. Seven patients carried the mutation in a homozygous, fourteen in a compound heterozygous state. The most common clinical diagnosis was LCA (16/24) followed by retinitis pigmentosa (RP, 7/24) and cone dystrophy (CD, 1/24). BCVA was severely reduced: 8/24 had no (NLP) or residual light perception (LP), and 6/24 had only hand motion vision (HM). Exceptions were 3 patients with BCVA of 0.8 (Snellen). All patients showed severely reduced or no measurable visual fields. ERG was typically undetectable, 3 patients with RP had preserved photopic responses. SD-OCT revealed centrally preserved photoreceptors in the milder RP cases and a complete photoreceptor loss in LCA and CD patients. Central foveal thickness was reduced (mean: 177µm ± 47µm), as well as outer nuclear layer (ONL) thickness (mean: 105 ± 27µm). Additional findings were nystagmus (75%), cataract (58%), keratoconus (17%), strabismus (38%) and the oculo-digital sign (17%). Interestingly, in patients with homozygous c.2991+1655A>G genotype, as well as in some compound heterozygous cases, FAF was absent.

Conclusions : c.2991+1655A>G is the most frequent mutation in CEP290 patients originating from Germany. A homozygous c.2991+1655A>G genotype was associated with the least favorable phenotype, however, clinical variability was observed. For future therapies, the affected gene as well as the presence of photoreceptors in SD-OCT might be most important to look out for.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×